Carrie Rubel

Company: Biogen

Job title: Scientific Director, Biomarkers

Seminars:

Panel Discussion: Evaluating the Current Landscape of Plasma-Based Markers of β-Amyloid Pathology in Alzheimer’s Disease & Mapping the Path to Widespread Blood Testing 9:30 am

How will the breakthroughs in blood-based amyloid biomarkers advance precision medicine? What are the opportunities for these β-amyloid assays to be used commercially to inform patient selection? How do we determine the right cut off, based on somebody’s age, gender, or phenotype, to deem a patient amyloid-positive and enrol them? Have there been advancements to…Read more

day: Pre-Conference Day